- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01659060
Chocolate Consumption in Healthy Pregnant Women Trial
August 2, 2012 updated by: Laval University
Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial
The purpose of this study is to to test the feasibility of design methods and procedures for later use on a larger scale and to examine the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function and blood pressure in healthy pregnant women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1V 0A6
- Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- non-smoking normotensive women aged from 18 to 35 years, between the 7 and 12 weeks of gestation (documented by ultrasound) and having a live fetus confirmed by fetal heart auscultation
Exclusion Criteria:
- Patients with family history of premature cardiovascular disease
- Chronic hypertension
- Currently or previously use of medications interfering with glucose or lipids metabolism.
- Use of supplements or natural health products that interfere with blood pressure.
- Consumption of 1 or more alcohol drink per day.
- Allergy or intolerance to nuts or chocolate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dark chocolate
|
The primary objective of this pilot RCT is to test the feasibility of design methods and procedures for later use on a larger scale.
The secondary objective is to examine the acute and chronic effect of dark chocolate on endothelial function and blood pressure, among healthy pregnant women.
Other Names:
|
Placebo Comparator: Placebo chocolate
|
Placebo intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in endothelial function and blood pressure
Time Frame: within the first 12 weeks of chocolate intake (week 12 and baseline)
|
within the first 12 weeks of chocolate intake (week 12 and baseline)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes from baseline in plasma flavanol and methylxanthines(caffeine, theobromine and theophylline) concentrations at 12 weeks
Time Frame: within the first 12 weeks of chocolate intake (week 12 and baseline)
|
within the first 12 weeks of chocolate intake (week 12 and baseline)
|
Weight change from baseline at 12 weeks
Time Frame: within the first 12 weeks of chocolate intake (week 12 and baseline)
|
within the first 12 weeks of chocolate intake (week 12 and baseline)
|
Number of participants with digestive and other signs and symptoms (nausea, abdominal pain, constipation, and headache)
Time Frame: within the first 12 weeks of chocolate intake (week 12 and baseline)
|
within the first 12 weeks of chocolate intake (week 12 and baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
April 1, 2009
Study Completion (Actual)
April 1, 2009
Study Registration Dates
First Submitted
July 31, 2012
First Submitted That Met QC Criteria
August 2, 2012
First Posted (Estimate)
August 7, 2012
Study Record Updates
Last Update Posted (Estimate)
August 7, 2012
Last Update Submitted That Met QC Criteria
August 2, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 119.05.03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension Pregnancy-induced
-
Minia UniversityRecruitingPregnancy Induced HypertensionEgypt
-
Georges HatemCompletedDevelopment and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced HypertensionPregnancy Related | Hypertension in PregnancyLebanon
-
Indonesia UniversityCompletedPregnancy Induced HypertensionIndonesia
-
King's College Hospital NHS TrustBarts and the London School of Medicine and Dentistry; Fetal Medicine FoundationUnknownPre-Eclampsia | Hypertension in Pregnancy | Gestational Hypertension | Pregnancy Induced HypertensionUnited Kingdom
-
Columbia UniversityNot yet recruitingPostpartum Preeclampsia | Hypertensive Emergency | Postpartum Pregnancy-Induced Hypertension | Pregnancy-Induced Hypertension in PostpartumUnited States
-
Federal University of ParaíbaCompletedHypertension | Pregnancy-Induced Hypertension in Postpartum | Postpartum Pre-EclampsiaBrazil
-
Bournemouth UniversitySuspendedPregnancy-Induced HypertensionUnited Kingdom
-
University of CalgaryActive, not recruitingPregnancy Related | Pregnancy Induced Hypertension
-
Ohio State UniversityCompletedHypertension | Preeclampsia | Pregnancy Induced HypertensionUnited States
-
Brigham and Women's HospitalSuspendedPreeclampsia | Pregnancy Induced HypertensionUnited States
Clinical Trials on Placebo Chocolate
-
Laval UniversityCompleted
-
Queen Margaret UniversityBarry CallebautCompletedBody WeightUnited Kingdom
-
University of SaskatchewanCompleted
-
Queen Margaret UniversityBarry CallebautCompletedInsulin ResistanceUnited Kingdom
-
Universidad de AntioquiaTerminated
-
Florida State UniversityCompleted